CAS 1279680-68-0

CL2A-SN-38

CAS : 1279680-68-0

Formule : C₇₃H₉₇N₁₁O₂₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 1480.6118

Ref: IN-DA01LI9G

CL2A-SN-38

CAS : 1279680-68-0

CL2A-SN-38

Degré de pureté : ≥95%

Masse moléculaire : 1480.61g/mol

Ref: 54-BUP04999

CL2A-SN-38

CAS : 1279680-68-0

CL2A-SN-38 delivers active active molecules within tumor cells and in the tumor microenvironment.

Formule : C₇₃H₉₇N₁₁O₂₂

Degré de pureté : 95.60%

Couleur et forme : Solid

Masse moléculaire : 1480.61

Ref: TM-T17731

Cl2A-SN-38

CAS : 1279680-68-0

Cl2A-SN-38 is an innovative antibody-drug conjugate (ADC), which is derived from a targeted delivery system designed to enhance the therapeutic index of chemotherapeutic agents. The product is synthesized through the chemical conjugation of the monoclonal antibody Cl2A with the potent topoisomerase I inhibitor, SN-38. This conjugation is achieved using a stable linker that facilitates selective delivery of SN-38 to cancer cells expressing the target antigen, thus minimizing systemic toxicity.

Formule : C₇₃H₉₇N₁₁O₂₂

Degré de pureté : Min. 95%

Masse moléculaire : 1,480.6 g/mol

Ref: 3D-EBC68068